ANI Pharmaceuticals | ANIP - Ebit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

ANI Pharmaceuticals

ANI Pharmaceuticals reported $11.02M in EBIT for its fiscal quarter ending in March of 2023.


Ebit Change
ANI Pharmaceuticals ANIP:US USD 11.02M 7.64M
Eli Lilly LLY:US USD 1.6B 515.6M
Endo International ENDP:US USD 104.03M 49.74M
Hikma Pharmaceutical HIK:LN USD 253M 3M
Knight Therapeutics Inc GUD:CN CAD 5.63M 14.29M
Nektar Therapeutics NKTR:US USD -37016000 3.87M
Novartis NVS:US USD 3.23B 123M
Perrigo PRGO:US USD 51.9M 7.6M
Sun Pharmaceuticals SUNP:IN INR 21.58B 1.89B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 776M 223M